梅因制药的股价下跌至38.6%,原因是澳大利亚财政部长考虑是否阻止该公司的收购要约。
梅因制药的股价下跌至38.6%,原因是澳大利亚财政部长考虑是否阻止该公司的收购要约。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.